ATH 25.0% 0.5¢ alterity therapeutics limited

Ann: Appendix 4E & Annual Report 2022, page-14

  1. 1,259 Posts.
    lightbulb Created with Sketch. 491
    Interesting that Geoffrey Kempler received a 'termination benefit' of a lazy $1,000,000 when he stepped down as CEO and assumed the role of non-executive Chairman. Wow, just wow.

    I personally think David Stamler stepping into the role will be a good change for Alterity. The financial reports make for pretty grim reading. Over $180m in accumulated losses. Yikes.

    As a former investor, I've been watching Prana / Alterity with interest for many years. Hope the ATH-434 trials are a success and the long termers here (some of my family members included) are justly rewarded.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $9.206K 2.091M

Buyers (Bids)

No. Vol. Price($)
58 74436855 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 29927588 19
View Market Depth
Last trade - 12.07pm 06/06/2024 (20 minute delay) ?
Last
0.4¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.4¢ 143255
Last updated 12.07pm 06/06/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.